Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms.


Journal

Journal of cardiac failure
ISSN: 1532-8414
Titre abrégé: J Card Fail
Pays: United States
ID NLM: 9442138

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 07 04 2020
revised: 14 04 2020
accepted: 15 04 2020
pubmed: 22 4 2020
medline: 10 7 2020
entrez: 22 4 2020
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) is a pandemic that has affected more than 1.8 million people worldwide, overwhelmed health care systems owing to the high proportion of critical presentations, and resulted in more than 100,000 deaths. Since the first data analyses in China, elevated cardiac troponin has been noted in a substantial proportion of patients, implicating myocardial injury as a possible pathogenic mechanism contributing to severe illness and mortality. Accordingly, high troponin levels are associated with increased mortality in patients with COVID-19. This brief review explores the available evidence regarding the association between COVID-19 and myocardial injury.

Identifiants

pubmed: 32315733
pii: S1071-9164(20)30357-2
doi: 10.1016/j.cardfail.2020.04.009
pmc: PMC7166030
pii:
doi:

Substances chimiques

Cytokines 0
Troponin 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

470-475

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
Adv Clin Chem. 2017;82:47-70
pubmed: 28939213
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
JAMA Cardiol. 2016 Jun 1;1(3):274-81
pubmed: 27438105
Sci China Life Sci. 2020 Mar;63(3):457-460
pubmed: 32009228
Arch Pathol Lab Med. 2004 Feb;128(2):195-204
pubmed: 14736283
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):456-460
pubmed: 32171190
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Clin Sci (Lond). 2005 Mar;108(3):205-13
pubmed: 15540988
Crit Care Med. 2003 Apr;31(4 Suppl):S213-20
pubmed: 12682443
Adv Pharmacol Sci. 2015;2015:507151
pubmed: 26064103
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Cardiovasc Res. 2020 May 1;116(6):1097-1100
pubmed: 32227090
Eur Heart J. 2020 May 14;41(19):1798-1800
pubmed: 32186331
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Semin Immunol. 2016 Dec;28(6):561-569
pubmed: 27866916
Circulation. 2007 Jan 2;115(1):5-8
pubmed: 17200452
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
N Engl J Med. 2018 Jan 25;378(4):345-353
pubmed: 29365305
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Thromb Haemost. 2020 May;18(5):1020-1022
pubmed: 32239799
Infez Med. 2016 Dec 1;24(4):340-344
pubmed: 28011972
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Med Virol. 2014 Dec;86(12):2146-53
pubmed: 24760654
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Cell Mol Life Sci. 2000 Apr;57(4):552-60
pubmed: 11130455
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Curr Opin Nephrol Hypertens. 2011 Jan;20(1):62-8
pubmed: 21099686
Thromb Res. 2008;122(6):743-52
pubmed: 17727922
Thromb Haemost. 2009 Nov;102(5):823-8
pubmed: 19888515
Eur Heart J. 2020 May 14;41(19):1858
pubmed: 32227120
Am J Emerg Med. 2020 May;38(5):998-1006
pubmed: 31864875
N Engl J Med. 2004 Dec 16;351(25):2611-8
pubmed: 15602021
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
J Pathol. 2003 Jul;200(3):282-9
pubmed: 12845623
JAMA Cardiol. 2020 Jul 1;5(7):751-753
pubmed: 32219362
Cell. 2011 Sep 16;146(6):980-91
pubmed: 21925319
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
J Biol Regul Homeost Agents. 2020 Mar 31;34(2):333-338
pubmed: 32228825
Eur Heart J. 2007 May;28(10):1205-10
pubmed: 17440221
Chest. 2019 Dec;156(6):1080-1091
pubmed: 31381883
Eur Heart J. 2020 May 14;41(19):1801-1803
pubmed: 32196087
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Thromb Haemost. 2014 Apr 1;111(4):625-33
pubmed: 24336942
Circ Res. 2016 Apr 15;118(8):1313-26
pubmed: 27081112
J Formos Med Assoc. 2014 Mar;113(3):148-54
pubmed: 24495555
Eur J Clin Invest. 2009 Jul;39(7):618-25
pubmed: 19453650
Circulation. 2020 May 26;141(21):1665-1666
pubmed: 32242749
Intensive Care Med. 2020 Jun;46(6):1114-1116
pubmed: 32236644
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Ann Am Thorac Soc. 2019 May;16(5):606-612
pubmed: 30521759
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300
J Thromb Thrombolysis. 2021 May;51(4):1107-1110
pubmed: 32246317
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Am Heart Assoc. 2020 Apr 7;9(7):e016219
pubmed: 32233755
J Infect. 2020 Jun;80(6):639-645
pubmed: 32240670
Med Microbiol Immunol. 2004 May;193(2-3):121-6
pubmed: 12920582
Infection. 2020 Oct;48(5):773-777
pubmed: 32277408
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Thromb Haemost. 2017 Feb 28;117(3):437-444
pubmed: 27975101
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904

Auteurs

Gregorio Tersalvi (G)

Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland; Department of Internal Medicine, Hirslanden Klinik St. Anna, Lucerne, Switzerland. Electronic address: tersalvi@gmail.com.

Marco Vicenzi (M)

Cardiovascular Disease Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Davide Calabretta (D)

Department of Anesthesia and Intensive Care Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Luigi Biasco (L)

Division of Cardiology, Ospedale di Ciriè, Ciriè, Italy; Department of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland.

Giovanni Pedrazzini (G)

Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland; Department of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland.

Dario Winterton (D)

Department of Anesthesia and Intensive Care Medicine, ASST Monza, Monza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH